|
|
|||||||
| Japanese | English | |||||
 |
|||||
|
|||||
 |
Strain List |
First Previous 1-50 51-100 101-150 151-200 Next Last
| Card Id | Type Of Strain | Strain Name | Internal Code | Gene Symbol | Gene Name | Disease | Stock Type | Submitter | Developer | imsr |
|
{251}
|
Targeted mutant. | 129-Ttrtm1 | Mshum1,M | Ttr | transthyretin |
Development Immunology Metabolism Neurobiology |
Unknown Unknown |
Shuichiro Maeda Dr. EJ R(The First Department of Biochemistry Yamanashi Medical University) Shuichiro Maeda Dr. EJ R(Columbia University) |
Released publicly | |
|
{578}
|
Targeted mutant. | 129/Sv.129S4(ICR)-Parp1tm1Hsmm/Hsmm |
129/Sv.129S4(ICR)-Parp1tm1Hsmm/Hsmm |
Parp1 | Poly (ADP-ribose) polymerase family, member 1 |
Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
Hiroshi Suzuki, Mitsuko Masutani(Chugai Pharmaceutical Co. Ltd., National Cancer Center Research Institute) |
||
|
{1433}
|
Inbred. | B10.A/Ham | B10.A/Ham | Immunology | Kato Hideki | Masakazu Hattori(Harvard Medical School, MA, USA) | ||||
|
{1117}
|
Inbred. | B10.NRH-Thy1a/Nrs | B10Thy1 | Immunology | - - |
Yoshiharu Yonekura(National Institute of Radiological Sciences) |
||||
|
{718}
|
Gene trap. | B6-Cd99Gt(pU-21T)44Imeg | Ayu21-B6T44 | Cd99 (synonym: Pilr-1) | CD99 antigen |
Development Immunology |
Masatake ARAKI |
Kimi Araki(Institute of Molecular Embryology and Genetics Kumamoto University) |
||
|
{1838}
|
Targeted mutant. | B6-Mir142tm1Card | 21-KBW111reKO17 | Mir142 | microRNA 142 |
Dermatology Development Hematology Immunology |
Masatake ARAKI | |||
|
{1851}
|
Targeted mutant. | B6-Rpt3tm1 | floxed Rpt3 | Psmc4 | proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
Aging Behavior Cell biology Dentistry Dermatology Development Diabetes Digestive Disorders Endocrine Disorders Genetics Hematology Immunology Laboratory-animal Science Metabolism Molecular biology Neurobiology Obesity Ophthalomology Osteosis Otorhinology Reproduction Respiratory System Urology cancer infectious peromelia |
Takahashi Ryosuke |
Yoshitaka Tashiro , Ryousuke Takahashi(Department of Neurology kyoto University Graduate School of Medicine) |
||
|
{1517}
|
Transgenic. | B6-Tg(CAG-Ulbp1)11Nsa | B6-Tg(CAG-Ulbp1)11Nsa | Ulbp1 | UL16 binding protein 1 |
Immunology cancer |
Nobuo SAKAGUCHI |
Kazuhiko Kuwahara, Nobuo Sakaguchi(Kumamoto University) |
||
|
{1448}
|
Transgenic. | B6-Tg(CAG-Ulbp1)12Nsa | B6-Tg(CAG-Mult1S)12Nsa | Ulbp1 (synonym for Mult1) | UL16 binding protein 1 |
Immunology cancer |
Nobuo SAKAGUCHI |
Kazuhiko Kuwahara, Nobuo Sakaguchi(Kumamoto University) |
||
|
{1518}
|
Transgenic. | B6-Tg(CAG-Ulbp1)14Nsa | B6-Tg(CAG-Ulbp1)14Nsa | Ulbp1 | UL16 binding protein 1 |
Immunology cancer |
Nobuo SAKAGUCHI |
Kazuhiko Kuwahara, Nobuo Sakaguchi(Kyoto University) |
||
|
{1449}
|
Transgenic. | B6-Tg(CAG-Ulbp1)41Nsa | B6-Tg(CAG-Mult1S)41Nsa | Ulbp1 (synonym for Mult1) | UL16 binding protein 1 |
Immunology cancer |
Nobuo SAKAGUCHI |
Kazuhiko Kuwahara, Nobuo Sakaguchi(Kumamoto University) |
||
|
{1447}
|
Transgenic. | B6-Tg(CAG-Ulbp1)7Nsa | B6-Tg(CAG-Mult1S)7Nsa | Ulbp1 (synonym for Mult1) | UL16 binding protein 1 |
Immunology cancer |
Nobuo SAKAGUCHI |
Kazuhiko Kuwahara, Nobuo Sakaguchi(Kumamoto University) |
||
|
{2984}
|
Transgenic. | B6-Tg(MC1neopA-hCD2p-c-Maf-LCR)21Card | 6NK-cMaf21 | Maf | avian musculoaponeurotic fibrosarcoma oncogene homolog |
Immunology Laboratory-animal Science cancer |
Araki Kimi |
Kimi Araki(Institute of Resource Development and Analysis, Kumamoto University.) |
||
|
{2985}
|
Transgenic. | B6-Tg(MC1neopA-hCD2p-c-Maf-LCR)22Card | 6NK-cMaf22 | Maf | avian musculoaponeurotic fibrosarcoma oncogene homolog |
Immunology Laboratory-animal Science cancer |
Araki Kimi |
Kimi Araki(Institute of Resource Development and Analysis, Kumamoto University.) |
||
|
{2986}
|
Transgenic. | B6-Tg(MC1neopA-hCD2p-c-Maf-LCR)27Card | 6NK-cMaf27 | Maf | avian musculoaponeurotic fibrosarcoma oncogene homolog |
Immunology Laboratory-animal Science cancer |
Araki Kimi |
Kimi Araki(Institute of Resource Development and Analysis, Kumamoto University.) |
||
|
{2987}
|
Transgenic. | B6-Tg(MC1neopA-hCD2p-c-Maf-LCR)39Card | 6NK-cMaf39 | Maf | avian musculoaponeurotic fibrosarcoma oncogene homolog |
Immunology Laboratory-animal Science cancer |
Araki Kimi |
Kimi Araki(Institute of Resource Development and Analysis, Kumamoto University.) |
||
|
{580}
|
Targeted mutant. | B6.129(ICR)-Parp1tm1Hsmm/Hsmm |
B6.129(ICR)-Parp1tm1Hsmm/Hsmm |
Parp1 | Poly (ADP-ribose) polymerase family, member 1 |
Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
Hiroshi Suzuki, Mitsuko Masutani(Chugai Pharmacetical Co. Ltd., National Cancer Center Reasearch Institute) |
||
|
{539}
|
Targeted mutant. | B6.129-Chrm1tm1 |
1NJ B6.129-Chrm1tm1 |
Chrm1 | cholinergic receptor, muscarinic 1, CNS |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI Minoru(Graduate Sch. Pharm, Sci., Univ.Tokyo) |
||
|
{534}
|
Targeted mutant. | B6.129-Chrm2tm1 |
2NJ B6.129-Chrm2tm1 |
Chrm2 | cholinergic receptor, muscarinic 2, cardiac |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo) |
Released publicly | |
|
{540}
|
Targeted mutant. | B6.129-Chrm3tm1 |
3NJ B6.129-Chrm3tm1 |
Chrm3 | cholinergic receptor, muscarinic 3, cardia |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo) |
Released publicly | |
|
{535}
|
Targeted mutant. | B6.129-Chrm4tm1 |
4NJ B6.129-Chrm4tm1 |
Chm4 | cholinergic receptor, muscarinic 4 |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI Minoru(Graduate Sch.Pharm. Sci., Univ. Tokyo) |
Released publicly | |
|
{541}
|
Targeted mutant. | B6.129-Chrm5tm1 |
5NJ B6.129-Chrm5tm1 |
Chrm5 | cholinergic receptor, muscarinic 5 |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI Minoru(東京大学薬学部) |
Released publicly | |
|
{1093}
|
Targeted mutant. | B6.129-Edg3tm1Jch | SIP3-Knockout | Edg3 | endothelial differentiation, sphingolipid G-protein-coupled receptor,3 |
Development Immunology Metabolism Neurobiology Physiology |
ISHII ISAO |
Isao Ishii(Showa Pharmaceutical University) Dr. Jerold Chun(The Scripps Research Institute) |
||
|
{576}
|
Targeted mutant. | B6.129-Jak3tm1CARD Rag2tm1CARD |
Jak3/Rag2 KO B6.129-Jak3tm1CARD Rag2tm1CARD |
Jak3 Rag2 |
Janus kinase 3,The Institute of Physical and Chemical Research,RIKEN recombination activating gene 2,The Institute of Physical and Chemical Research,RIKEN |
Development Immunology |
Unknown Unknown |
Takashi Saito |
||
|
{577}
|
Targeted mutant. | B6.129-Jak3tm1CARD |
Jak 3 KO B6.129-Jak3tm1CARD |
Jak3 | Janus kinase 3,The Institute of Physical and Chemical Research,RIKEN |
Development Immunology |
Unknown Unknown |
Takashi Saito (Takashi Saito) |
||
|
{518}
|
Targeted mutant. | B6.129-Msr1tm1Csk |
SR-A KO B6.129-Msr1tm1Csk |
Msr1 | macrophage Scavenger receptor 1 |
Anatomy Immunology Metabolism |
Unknown Unknown |
(Chugai Pharmacentical. Co, Ltd.) |
Released publicly | |
|
{1251}
|
Targeted mutant. | B6.129-Neu3tm1Myg | C57BL/6-Neu3tm1Myg | Neu3 | neuraminidase3 |
Immunology Metabolism Neurobiology Physiology cancer |
Yamaguchi Kazunori |
Taeko Miyagi(Miyagi Cancer Center Research Institute) |
||
|
{2663}
|
Targeted mutant. | B6.129-Pkmtm1Ntan | PkmM1 | Pkm | pyruvate kinase, muscle |
Development Immunology Metabolism Neurobiology Physiology cancer |
Tanuma Nobuhiro |
Nobuhiro Tanuma(Miyagi Cancer Center Research Institute) |
||
|
{1992}
|
Targeted mutant. | B6.129-Ptger2tm1Sna | EP2KO | Ptger2 | prostaglandin E receptor 2 (subtype EP2) |
Dermatology Development Immunology Neurobiology Physiology cancer |
Narumiya Shuh |
Shuh Narumiya(Kyoto University Graduate School of Medicine, Department of pharmacology) |
||
|
{1073}
|
Targeted mutant. | B6.129-S1pr2tm1Jch | SIP2-Knockout | S1pr2 (Synonym: Edg5) | Endothelial differentiation, sphingolipid G-protein-coupled receptor,5 |
Dermatology Development Immunology Metabolism Neurobiology Physiology |
ISHII ISAO |
Isao Ishii(Showa Pharmaceutical University) Dr. Jerold Chun(The Scripps Research Institute) |
||
|
{1277}
|
Transgenic. | B6.BDF1-Tg(CAG-Cat-vIL10)Miya | CAG-CAT-vIL10 | viral interleukin 10 | vIL10 |
Immunology Metabolism |
Miyazaki Jun-ichi |
Jun-ichi Miyazaki(Osaka University Graduate School of Medicine) |
||
|
{1142}
|
Transgenic. | B6.Cg-Tg(CAG-cre)CZ-MO2Osb | (CAG-cre) | Cre | Cre recombinase |
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer |
Masaru Okabe |
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University) |
||
|
{1143}
|
Transgenic. | B6.Cg-Tg(CAG-floxed Neo-EGFP)REP08Osb | REP-08 | EGFP | green fluorescent protein |
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer |
Masaru Okabe |
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University) |
||
|
{2296}
|
Inbred. | B6.D2-(D14Mit11-D14Mit54)Hkv | B6.D2-Sev3 | Immunology | Agui Takashi |
Takashi Agui(Graduate School of Veterinary Medicine, Hokkaido University) |
||||
|
{2295}
|
Inbred. | B6.D2-(D3Mit221-D3Mit208)Hkv | B6.D2-Sev2 | Immunology | Agui Takashi |
Takashi Agui(Graduate School of Veterinary Medicine, Hokkaido University) |
||||
|
{2294}
|
Inbred. | B6.D2-(D4Mit327-D4Mit42)Hkv | B6.D2-Sev1 | Immunology | Agui Takashi |
Takashi Agui(Graduate School of Veterinary Medicine, Hokkaido University) |
||||
|
{1144}
|
Transgenic. | B6.D2-Tg(CAG-floxed Neo-DT)03Osb | REP-DT | DT | Diphtheria toxin gene subunit A |
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer |
Masaru Okabe |
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University) |
||
|
{585}
|
Targeted mutant. | B6;129(ICR)-Parp1tm1Hsmm Tg(GPT-delta)/Hsmm | B6;129(ICR)-Parp1tm1Hsmm TgN(GPT-delta)/Hsmm |
Parp1 Parp1 |
Poly (ADP-ribose) polymerase family, member 1 Poly (ADP-ribose) polymerase family, member 1 |
Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
Hiroshi Suzuki, Mitsuko Masutani(Chugai Pharmaceutical Co. Ltd., National Cancer Center Research Institute) |
||
|
{278}
|
Targeted mutant. | B6;129-Bcl6tm1 |
Bcl6 KO Bcl6 KO (F1) |
Bcl6 | B-cell leukemia/lymphoma 6 |
Development Immunology Neurobiology |
Masahiko Hatano |
Masahiko Hatano(Chiba Univ. School of Medicine) |
Released publicly | |
|
{550}
|
Targeted mutant. | B6;129-Cd51tm1 |
AIM-/-BL B6;129-Cd51tm1 |
Cd51(Synonym:Aim) | CD5 antigen-like |
Immunology Metabolism |
Miyazaki Toru |
Toru Miyazaki(University of Texas Southwestern Medical Center) |
Released publicly | |
|
{764}
|
Targeted mutant. | B6;129-Chrm1tm1 Chrm2tm1 Chrm4tm1 | M1M2M4KO |
Chrm1 Chrm2 Chrm4 |
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 2 cholinergic receptor, muscarinic 4 |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo) |
||
|
{765}
|
Targeted mutant. | B6;129-Chrm1tm1 Chrm3tm1 Chrm5tm1 | M1M3M5KO |
Chrm1 Chrm3 Chrm5 |
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 5 |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo) |
||
|
{766}
|
Targeted mutant. | B6;129-Chrm1tm1 Chrm3tm1 | M1M3KO |
Chrm1 Chrm3 |
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 3, cardiac |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo) |
||
|
{773}
|
Targeted mutant. | B6;129-Chrm2tm1 Chrm4tm1 | M2M4KO, C57BL/6J, 2x4 |
Chrm2 Chrm4 |
cholinergic receptor, muscarinic 2, cardiac cholinergic receptor, muscarinic 4 |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo) |
||
|
{771}
|
Targeted mutant. | B6;129-Chrm2tm1 Chrm5tm1 | 2x5 |
Chrm2 Chrm5 |
cholinergic receptor, muscarinic 2, cardiac cholinergic receptor, muscarinic 5 |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI, Minoru |
||
|
{770}
|
Targeted mutant. | B6;129-Chrm3tm1 Chrm4tm1 | 3x4 |
Chrm3 Chrm4 |
cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 4 |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo) |
||
|
{774}
|
Targeted mutant. | B6;129-Chrm3tm1 Chrm5tm1 | 3x5 |
Chrm3 Chrm5 |
cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 5 |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo) |
||
|
{772}
|
Targeted mutant. | B6;129-Chrm4tm1 Chrm5tm1 | M4M5KO, C57BL/6J, 4x5 |
Chrm4 Chrm5 |
cholinergic receptor, muscarinic 4 cholinergic receptor, muscarinic 5 |
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer |
Unknown Unknown |
MATSUI, Minoru(Graduate Sch. pharm. Sci., Univ. Tokyo) |
||
|
{2193}
|
Targeted mutant. | B6;129-Clec4etm1(GFP-IRES-DTR)Sym | Mincle-GID | Clec4e | C-type lectin domain family 4, membere |
Immunology infectious |
Yamasaki Sho | |||
|
{1683}
|
Targeted mutant. | B6;129-Cxcl14tm1 | Cxcl14-KO | Cxcl14 | chemokine (C-X-C motif) ligand 14 |
Immunology cancer |
Masanobu Oshima |
Hiroko Oshima(Cancer Res. Institute, Kanazawa Univ) |
|
Copyright @ 2008 Kumamoto University. All rights reserved. |